Considerations for the use of progestin-only contraceptives

Journal of American an Academy of Nurse Practitioners

Volumn 22, Issue 2, 2010, Pages 81-91

  Freeman, Sarah ^a   Shulman, Lee P ^b  

^a EMORY UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Contraception; Implant; Injectable; Intrauterine; Progestin only

Indexed keywords

3 KETO DESOGESTREL; 3-KETO-DESOGESTREL; CONTRACEPTIVE AGENT; DESOGESTREL; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; NORGESTREL; ORAL CONTRACEPTIVE AGENT; POSTCOITUS CONTRACEPTIVE AGENT; PROGESTERONE DERIVATIVE;

CHEMICALLY INDUCED DISORDER; COUNSELING; EDUCATION; FAMILY PLANNING; HEALTH PROMOTION; METHODOLOGY; NEOPLASM; NURSING; PATIENT EDUCATION; PATIENT SELECTION; PRESCRIPTION; REVIEW; RISK FACTOR; STATISTICS; UNITED STATES; UNPLANNED PREGNANCY;

EID: 77449136430     PISSN: 10412972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2009.00473.x     Document Type: Review

References (102)